Literature DB >> 8468929

Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis.

Y Horii1, M Iwano, E Hirata, M Shiiki, Y Fujii, K Dohi, H Ishikawa.   

Abstract

Mesangial proliferative glomerulonephritis (mesPGN) is histologically characterized by proliferation of mesangial cells (MC), suggesting the involvement of a growth factor for MC in the pathogenesis of mesPGN. We have previously shown that interleukin-6 (IL-6) induces proliferation of cultured rat mesangial cells, and urine samples from patients with IgA nephropathy contain high level of IL-6 activity. We have also demonstrated that transgenic mice carrying a human IL-6 genomic gene showed severe mesangial proliferation and matrix enlargement. Urinary samples of patients with lupus nephritis as well as IgA nephropathy contain significant IL-6 activity. Over a ten month follow-up, a positive correlation between the urinary IL-6 and pathological score was observed. Hence, measurement of urinary IL-6 can be used as a good indicator for monitoring IgA nephropathy and lupus nephritis. Using RT-PCR methods, IL-6 mRNA was detected in the glomeruli of renal biopsy specimens obtained from patients with IgA nephropathy and lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8468929

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  28 in total

Review 1.  Cytokines and systemic lupus erythematosus.

Authors:  G S Dean; J Tyrrell-Price; E Crawley; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

2.  Angioimmunoblastic T-cell lymphoma and membranous nephropathy: a still unreported association.

Authors:  Masaru Togashi; Hideki Wakui; Koya Kodama; Yoshihiro Kameoka; Atsushi Komatsuda; Takashi Nimura; Ryo Ichinohasama; Ken-Ichi Sawada
Journal:  Clin Exp Nephrol       Date:  2010-02-23       Impact factor: 2.801

3.  Effects of exercise in renal transplant recipients.

Authors:  Giulio Romano; Eric Lorenzon; Domenico Montanaro
Journal:  World J Transplant       Date:  2012-08-24

4.  The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.

Authors:  Roland Schmitt; Anne-Lie Ståhl; Anders I Olin; Ann-Charlotte Kristoffersson; Johan Rebetz; Jan Novak; Gunnar Lindahl; Diana Karpman
Journal:  J Immunol       Date:  2014-05-21       Impact factor: 5.422

Review 5.  The role of toll-like receptors in systemic lupus erythematosus.

Authors:  Adeeb H Rahman; Robert A Eisenberg
Journal:  Springer Semin Immunopathol       Date:  2006-09-19

6.  Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in Faslpr Mice.

Authors:  Yi Zhou; Huimei Chen; Li Liu; Xueqing Yu; Galina K Sukhova; Min Yang; Vasileios C Kyttaris; Isaac E Stillman; Bruce Gelb; Peter Libby; George C Tsokos; Guo-Ping Shi
Journal:  J Immunol       Date:  2017-01-16       Impact factor: 5.422

7.  Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.

Authors:  B Ryffel; B D Car; H Gunn; D Roman; P Hiestand; M J Mihatsch
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

Review 8.  Cytokines in systemic lupus erythematosus.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

Review 9.  Expression of cytokines and growth factors in human glomerulonephritides.

Authors:  R Waldherr; I L Noronha; Z Niemir; C Krüger; H Stein; G Stumm
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

10.  Successful treatment of recurrent pleural and pericardial effusions with tocilizumab in a patient with systemic lupus erythematous.

Authors:  Vanessa Ocampo; Derek Haaland; K Legault; Shika Mittoo; Emily Aitken
Journal:  BMJ Case Rep       Date:  2016-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.